OCT 27, 2026 · JOURNAL ARTICLE
Late-onset Vitiligo Associated with Prolonged Ribociclib Therapy in Metastatic Breast Cancer: A Case Report
Journal of Cancer Research and Practice
Abstract Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) are a cornerstone in the treatment of estrogen receptor-positive, progesterone receptor-positive metastatic breast can